BIIB
Health CareBiogen Inc
Biotechnology
14-Day MFI Score
56.14
Signal Status
—
Signal strength 13% — conviction of the current signal (0–100)
Money Flow Index (14D)
56.14 / 100
Momentum Inflow
Relative Strength vs SPY
-0.3%
20-Day Trend Momentum
Volume Z-Score
0.57
Volume vs 20-day average (−3σ … +3σ) · normal range
28-Yr Backtest Rank
Top 13.2%
Deterministic Historical Percentile
Daily Bars — BIIB
Latest 13F Institutional Positions
| Institutional Filer | CIK | Shares Held | Quarterly Shift |
|---|---|---|---|
| PRIMECAP MANAGEMENT CO/CA/ | 0000763212 | 14,757,607 | 0.0% |
| Sofinnova Investments, Inc. | 0001631134 | 229,521 | — |
| Logos Global Management LP | 0001792126 | 200,000 | 0.0% |
| Palo Alto Investors LP | 0001306923 | 140,719 | -23.3% |
| Portolan Capital Management, LLC | 0001350290 | 118,481 | +39.4% |
Top-5 holders by shares held, latest 13F snapshot (Δshares disclosed per filing). Quarterly shift = % change in position.
Qualitative Tear Sheet
Tear sheet can be requested from our qualitative research AdCho.com
Newsletter signup
Free subscription. Daily trading day morning dispatch. No spam.